Top

Published in:

Open Access 01-12-2021 | Radiotherapy | Educational Review

Imaging side effects and complications of chemotherapy and radiation therapy: a pictorial review from head to toe

Authors: Domenico Albano, Massimo Benenati, Antonio Bruno, Federico Bruno, Marco Calandri, Damiano Caruso, Diletta Cozzi, Riccardo De Robertis, Francesco Gentili, Irene Grazzini, Giuseppe Micci, Anna Palmisano, Carlotta Pessina, Paola Scalise, Federica Vernuccio, Antonio Barile, Vittorio Miele, Roberto Grassi, Carmelo Messina, Young SIRM Working Group

Published in: Insights into Imaging | Issue 1/2021

Abstract

Newer biologic drugs and immunomodulatory agents, as well as more tolerated and effective radiation therapy schemes, have reduced treatment toxicity in oncology patients. However, although imaging assessment of tumor response is adapting to atypical responses like tumor flare, expected changes and complications of chemo/radiotherapy are still routinely encountered in post-treatment imaging examinations. Radiologists must be aware of old and newer therapeutic options and related side effects or complications to avoid a misinterpretation of imaging findings. Further, advancements in oncology research have increased life expectancy of patients as well as the frequency of long-term therapy-related side effects that once could not be observed. This pictorial will help radiologists tasked to detect therapy-related complications and to differentiate expected changes of normal tissues from tumor relapse.

Le Tourneau C, Borcoman E, Kamal M (2019) Molecular profiling in precision medicine oncology. Nat Med 25:711–712. https://doi.org/10.1038/s41591-019-0442-2CrossRefPubMed

Badalamenti G, Messina C, De Luca I, Musso E, Casarin A, Incorvaia L (2019) Soft tissue sarcomas in the precision medicine era: new advances in clinical practice and future perspectives. Radiol Med 124:259–265. https://doi.org/10.1007/s11547-018-0883-6CrossRefPubMed

Kucha N, Soni TP, Jakhotia N et al (2020) A prospective, comparative analysis of acute toxicity profile between three-dimensional conformal radiotherapy (3DCRT) and intensity-modulated radiotherapy (IMRT) in locally advanced head and neck cancer patients. Cancer Treat Res Commun 25:100223. https://doi.org/10.1016/j.ctarc.2020.100223CrossRefPubMed

Albano D, Stecco A, Micci G et al (2021) Whole-body magnetic resonance imaging (WB-MRI) in oncology: an Italian survey. Radiol Med 126:299–305. https://doi.org/10.1007/s11547-020-01242-7CrossRefPubMed

Messina C, Bignone R, Bruno A et al (2020) Diffusion-weighted imaging in oncology: an update. Cancers (Basel) 12(6):1493 https://doi.org/10.3390/cancers12061493CrossRef

García-Figueiras R, Baleato-González S, Padhani AR et al (2019) How clinical imaging can assess cancer biology. Insights Imaging. https://doi.org/10.1186/s13244-019-0703-0CrossRefPubMedPubMedCentral

Sun NN, Ge XL, Liu XS, Xu LL (2020) Histogram analysis of DCE-MRI for chemoradiotherapy response evaluation in locally advanced esophageal squamous cell carcinoma. Radiol Med 125:165–176. https://doi.org/10.1007/s11547-019-01081-1CrossRefPubMed

Cuccia F, Mortellaro G, Trapani G et al (2020) Acute and late toxicity and preliminary outcomes report of moderately hypofractionated helical tomotherapy for localized prostate cancer: a mono-institutional analysis. Radiol Med 125:220–227. https://doi.org/10.1007/s11547-019-01095-9CrossRefPubMed

Maturen KE, Feng MU, Wasnik AP et al (2013) Imaging effects of radiation therapy in the abdomen and pelvis: Evaluating “innocent bystander” tissues. Radiographics 33:599–619. https://doi.org/10.1148/rg.332125119CrossRefPubMed

10.

Ngo D, Jia JB, Green CS, Gulati AT, Lall C (2015) Cancer therapy related complications in the liver, pancreas, and biliary system: an imaging perspective. Insights Imaging 6:665–677. https://doi.org/10.1007/s13244-015-0436-7CrossRefPubMedPubMedCentral

11.

Soussain C, Ricard D, Fike JR, Mazeron J-J, Psimaras D, Delattre J-Y (2009) CNS complications of radiotherapy and chemotherapy. Lancet 374:1639–1651. https://doi.org/10.1016/S0140-6736(09)61299-XCrossRefPubMed

12.

Godi C, Falini A (2019) Radiological findings of drug-induced neurotoxic disorders. In: Clin. neuroradiol. Springer International Publishing, pp 1403–1429

13.

Cabaj A, Bekiesińska-Figatowska M, Duczkowska A, Duczkowski M (2016) Brain MRI findings in neurological complications of cancer treatment. Adv Clin Exp Med 25:789–797. https://doi.org/10.17219/acem/37716CrossRefPubMed

14.

Castellano A, Anzalone N (2019) Radiation and chemotherapy induced injury. In: Clin. neuroradiol. Springer International Publishing, pp 1431–1458

15.

Caranci F, Leone G, Ponsiglione A et al (2020) Imaging findings in hypophysitis: a review. Radiol Medica 125:319–328. https://doi.org/10.1007/s11547-019-01120-xCrossRef

16.

De Felice F, D’Angelo E, Ingargiola R et al (2020) A snapshot on radiotherapy for head and neck cancer patients during the COVID-19 pandemic: a survey of the Italian Association of Radiotherapy and Clinical Oncology (AIRO) head and neck working group. Radiol Med. https://doi.org/10.1007/s11547-020-01296-7CrossRefPubMedPubMedCentral

17.

De Felice F, Musio D, Tombolini V (2020) Weekly hypofractionated radiation therapy in elderly non-resectable cutaneous squamous cell carcinoma of the head and neck region. Radiol Med. https://doi.org/10.1007/s11547-020-01260-5CrossRefPubMedPubMedCentral

18.

Magrini SM, Pasinetti N, Belgioia L et al (2019) Applying radiation protection and safety in radiotherapy. Radiol Medica 124:777–782. https://doi.org/10.1007/s11547-019-01043-7CrossRef

19.

Stone HB, Coleman CN, Anscher MS, McBride WH (2003) Effects of radiation on normal tissue: consequences and mechanisms. Lancet Oncol 4:529–536. https://doi.org/10.1016/S1470-2045(03)01191-4CrossRefPubMed

20.

Hermans R (2008) Posttreatment imaging in head and neck cancer. Eur J Radiol 66:501–511. https://doi.org/10.1016/j.ejrad.2008.01.021CrossRefPubMed

21.

Saito N, Nadgir RN, Nakahira M et al (2012) Posttreatment CT and MR imaging in head and neck cancer: what the radiologist needs to know. Radiographics 32:1261–1282. https://doi.org/10.1148/rg.325115160CrossRefPubMed

22.

Debnam JM, Garden AS, Ginsberg LE (2008) Benign ulceration as a manifestation of soft tissue radiation necrosis: imaging findings. AJNR Am J Neuroradiol 29:558–562. https://doi.org/10.3174/ajnr.A0886CrossRefPubMedPubMedCentral

23.

Raggio BS, Winters R (2018) Modern management of osteoradionecrosis. Curr Opin Otolaryngol Head Neck Surg 26:254–259. https://doi.org/10.1097/MOO.0000000000000459CrossRefPubMed

24.

Giannini L, Incandela F, Fiore M et al (2018) Radiation-induced sarcoma of the head and neck: a review of the literature. Front Oncol. https://doi.org/10.3389/fonc.2018.00449CrossRefPubMedPubMedCentral

25.

Valeriani M, Marinelli L, Nicosia L et al (2019) Locally advanced inoperable primary or recurrent non-small cell lung cancer treated with 4-week hypofractionated radiation therapy (3 Gy/fraction). Radiol Medica 124:1324–1332. https://doi.org/10.1007/s11547-019-01064-2CrossRef

26.

Kim BH, Kim J-S, Kim KH, Moon HJ, Kim S (2020) Clinical significance of radiation dose–volume parameters and functional status on the patient-reported quality of life changes after thoracic radiotherapy for lung cancer: a prospective study. Radiol Med. https://doi.org/10.1007/s11547-020-01273-0CrossRefPubMed

27.

Giuranno L, Ient J, De Ruysscher D, Vooijs MA (2019) Radiation-induced lung injury (RILI). Front Oncol. https://doi.org/10.3389/fonc.2019.00877CrossRefPubMedPubMedCentral

28.

Borghetti P, Bonù ML, Giubbolini R et al (2019) Concomitant radiotherapy and TKI in metastatic EGFR- or ALK-mutated non-small cell lung cancer: a multicentric analysis on behalf of AIRO lung cancer study group. Radiol Med 124:662–670. https://doi.org/10.1007/s11547-019-00999-wCrossRefPubMed

29.

Giridhar P, Mallick S, Rath GK, Julka PK (2015) Radiation induced lung injury: Prediction, assessment and management. Asian Pacific J Cancer Prev 16:2613–2617. https://doi.org/10.7314/APJCP.2015.16.7.2613CrossRef

30.

Parisi G, Mazzola R, Ciammella P et al (2019) Hypofractionated radiation therapy in the management of locally advanced NSCLC: a narrative review of the literature on behalf of the Italian Association of Radiation Oncology (AIRO)—Lung Working Group. Radiol Medica 124:136–144. https://doi.org/10.1007/s11547-018-0950-zCrossRef

31.

Murofushi KN, Oguchi M, Gosho M, Kozuka T, Sakurai H (2015) Radiation-induced bronchiolitis obliterans organizing pneumonia (BOOP) syndrome in breast cancer patients is associated with age. Radiat Oncol. https://doi.org/10.1186/s13014-015-0393-9CrossRefPubMedPubMedCentral

32.

Skeoch S, Weatherley N, Swift A et al (2018) Drug-induced interstitial lung disease: a systematic review. J Clin Med 7:356. https://doi.org/10.3390/jcm7100356CrossRefPubMedCentral

33.

Torrisi JM, Schwartz LH, Gollub MJ, Ginsberg MS, Bosl GJ, Hricak H (2011) CT findings of chemotherapyinduced toxicity: what radiologists need to know about the clinical and radiologic manifestations of chemotherapy toxicity. Radiology 258:41–56. https://doi.org/10.1148/radiol.10092129CrossRefPubMed

34.

Limper AH (2004) Chemotherapy-induced lung disease. Clin Chest Med 25:53–64. https://doi.org/10.1016/S0272-5231(03)00123-0CrossRefPubMed

35.

Boiselle PM, Morrin MM, Huberman MS (2000) Gemcitabine pulmonary toxicity: CT features. J Comput Assist Tomogr 24:977–980. https://doi.org/10.1097/00004728-200011000-00027CrossRefPubMed

36.

Taunk NK, Haffty BG, Kostis JB, Goyal S (2015) Radiation-induced heart disease: pathologic abnormalities and putative mechanisms. Front Oncol. https://doi.org/10.3389/fonc.2015.00039CrossRefPubMedPubMedCentral

37.

Arslan A, Aktas E, Sengul B, Tekin B (2020) Dosimetric evaluation of left ventricle and left anterior descending artery in left breast radiotherapy. Radiol Med. https://doi.org/10.1007/s11547-020-01201-2CrossRefPubMed

38.

Darby SC, Ewertz M, McGale P et al (2013) Risk of ischemic heart disease in women after radiotherapy for breast cancer. N Engl J Med 368:987–998. https://doi.org/10.1056/nejmoa1209825CrossRef

39.

Whitlock MC, Yeboah J, Burke GL, Chen H, Klepin HD, Hundley WG (2015) Cancer and its association with the development of coronary artery calcification: an assessment from the multi-ethnic study of atherosclerosis. J Am Heart Assoc. https://doi.org/10.1161/JAHA.115.002533CrossRefPubMedPubMedCentral

40.

Rademaker J, Schöder H, Ariaratnam NS et al (2008) Coronary artery disease after radiation therapy for Hodgkin’s lymphoma: coronary CT angiography findings and calcium scores in nine asymptomatic patients. AJR Am J Roentgenol 191:32–37. https://doi.org/10.2214/AJR.07.3112CrossRefPubMed

41.

Küpeli S, Hazirolan T, Varan A et al (2010) Evaluation of coronary artery disease by computed tomography angiography in patients treated for childhood Hodgkin’s lymphoma. J Clin Oncol 28:1025–1030. https://doi.org/10.1200/JCO.2009.25.2627CrossRefPubMed

42.

Gujral DM, Lloyd G, Bhattacharyya S (2016) Radiation-induced valvular heart disease. Heart 102:269–276. https://doi.org/10.1136/heartjnl-2015-308765CrossRefPubMed

43.

Čelutkienė J, Pudil R, López-Fernández T et al (2020) Role of cardiovascular imaging in cancer patients receiving cardiotoxic therapies: a position statement on behalf of the Heart Failure Association (HFA), the European Association of Cardiovascular Imaging (EACVI) and the Cardio-Oncology Council of the Eur. Eur J Heart Fail 22:1504–1524. https://doi.org/10.1002/ejhf.1957CrossRefPubMed

44.

Galán-Arriola C, Lobo M, Vílchez-Tschischke JP et al (2019) Serial magnetic resonance imaging to identify early stages of anthracycline-induced cardiotoxicity. J Am Coll Cardiol 73:779–791. https://doi.org/10.1016/j.jacc.2018.11.046CrossRefPubMed

45.

Wang DY, Salem JE, Cohen JV et al (2018) Fatal toxic effects associated with immune checkpoint inhibitors: a systematic review and meta-analysis. JAMA Oncol 4:1721–1728. https://doi.org/10.1001/jamaoncol.2018.3923CrossRefPubMedPubMedCentral

46.

Vernuccio F, Dioguardi Burgio M, Barbiera F et al (2019) CT and MR imaging of chemotherapy-induced hepatopathy. Abdom Radiol (NY) 44:3312–3324. https://doi.org/10.1007/s00261-019-02193-yCrossRef

47.

Peppercorn PD, Reznek RH, Wilson P, Slevin ML, Gupta RK (1998) Demonstration of hepatic steatosis by computerized tomography in patients receiving 5-fluorouracil-based therapy for advanced colorectal cancer. Br J Cancer 77:2008–2011. https://doi.org/10.1038/bjc.1998.333CrossRefPubMedPubMedCentral

48.

Rubbia-Brandt L, Lauwers GY, Wang H et al (2010) Sinusoidal obstruction syndrome and nodular regenerative hyperplasia are frequent oxaliplatin-associated liver lesions and partially prevented by bevacizumab in patients with hepatic colorectal metastasis. Histopathology 56:430–439. https://doi.org/10.1111/j.1365-2559.2010.03511.xCrossRefPubMed

49.

Gatti M, Calandri M, Bergamasco L et al (2020) Characterization of the arterial enhancement pattern of focal liver lesions by multiple arterial phase magnetic resonance imaging: comparison between hepatocellular carcinoma and focal nodular hyperplasia. Radiol Med 125:348–355. https://doi.org/10.1007/s11547-019-01127-4CrossRefPubMed

50.

Hennedige TP, Hallinan JTPD, Leung FP et al (2016) Comparison of magnetic resonance elastography and diffusion-weighted imaging for differentiating benign and malignant liver lesions. Eur Radiol 26:398–406. https://doi.org/10.1007/s00330-015-3835-8CrossRefPubMed

51.

Vernuccio F, Godfrey D, Meyer M, et al (2019) Local tumor control and patient outcome using stereotactic body radiation therapy for hepatocellular carcinoma: IRECIST as a potential substitute for traditional criteria. AJR Am J Roentgenol 213(6):1232–1239

52.

Vernaleone M, Bonomo P, Di Cataldo V et al (2019) Robotic stereotactic radiotherapy for liver oligometastases from colorectal cancer: a single-center experience. Radiol Medica 124:870–876. https://doi.org/10.1007/s11547-019-01042-8CrossRef

53.

Falcinelli L, Mendichi M, Chierchini S et al (2020) Pulmonary function in stereotactic body radiotherapy with helical tomotherapy for primary and metastatic lung lesions. Radiol Med. https://doi.org/10.1007/s11547-020-01223-wCrossRefPubMed

54.

Yuan H, Liu F, Li X et al (2019) Transcatheter arterial chemoembolization combined with simultaneous DynaCT-guided radiofrequency ablation in the treatment of solitary large hepatocellular carcinoma. Radiol Medica. https://doi.org/10.1007/s11547-018-0932-1CrossRef

55.

Sangro B, Gil-Alzugaray B, Rodriguez J et al (2008) Liver disease induced by radioembolization of liver tumors: description and possible risk factors. Cancer 112:1538–1546. https://doi.org/10.1002/cncr.23339CrossRefPubMed

56.

Spina JC, Hume I, Pelaez A, Peralta O, Quadrelli M, Monaco RG (2019) Expected and unexpected imaging findings after 90 Y transarterial radioembolization for liver tumors. Radiographics 39:578–595. https://doi.org/10.1148/rg.2019180095CrossRefPubMed

57.

Badalov N, Baradarian R, Iswara K, Li J, Steinberg W, Tenner S (2007) Drug-induced acute pancreatitis: an evidence-based review. Clin Gastroenterol Hepatol. https://doi.org/10.1016/j.cgh.2006.11.023CrossRefPubMed

58.

Alessandrino F, Krajewski KM, Tirumani SH et al (2017) Biliary and pancreatic complications of molecular targeted therapies in cancer imaging. Abdom Radiol (NY) 42:1721–1733. https://doi.org/10.1007/s00261-017-1050-6CrossRef

59.

Eshet Y, Baruch EN, Shapira-Frommer R et al (2018) Clinical significance of pancreatic atrophy induced by immune-checkpoint inhibitors: A case–control study. Cancer Immunol Res 6:1453–1458. https://doi.org/10.1158/2326-6066.CIR-17-0659CrossRefPubMed

60.

Hajj C, Goodman KA (2015) Pancreatic cancer and SBRT: a new potential option? Reports Pract Oncol Radiother 20:377–384. https://doi.org/10.1016/j.rpor.2015.05.008CrossRef

61.

Bradley J, Movsas B (2006) Radiation pneumonitis and esophagitis in thoracic irradiation. Cancer Treat Res 128:43–64. https://doi.org/10.1007/0-387-25354-8_4CrossRefPubMed

62.

Benveniste MF, Gomez D, Carter BW et al (2019) Recognizing radiation therapy–related complications in the chest. Radiographics 39:344–366. https://doi.org/10.1148/rg.2019180061CrossRefPubMed

63.

Benveniste MF, Gomez D, Carter BW et al (2016) Radiation effects in the mediastinum and surroundings: imaging findings and complications. Semin Ultrasound CT MRI 37:268–280. https://doi.org/10.1053/j.sult.2015.11.002CrossRef

64.

Iyer R, Jhingran A (2006) Radiation injury: imaging findings in the chest, abdomen and pelvis after therapeutic radiation. Cancer Imaging. https://doi.org/10.1102/1470-7330.2006.9095CrossRefPubMedPubMedCentral

65.

Di Grezia G, Gatta G, Rella R et al (2019) MDCT in acute ischaemic left colitis: a pictorial essay. Radiol Med 124:103–108. https://doi.org/10.1007/s11547-018-0947-7CrossRefPubMed

66.

Lambregts DMJ, Boellaard TN, Beets-Tan RGH (2019) Response evaluation after neoadjuvant treatment for rectal cancer using modern MR imaging: a pictorial review. Insights Imaging. https://doi.org/10.1186/s13244-019-0706-xCrossRefPubMedPubMedCentral

67.

Spatola C, Privitera G, Milazzotto R et al (2019) Trends in combined radio-chemotherapy for locally advanced rectal cancer: a survey among radiation oncology centers of Sicily region on behalf of AIRO. Radiol Medica 124:671–681. https://doi.org/10.1007/s11547-019-01007-xCrossRef

68.

Ahualli J (2005) The target sign: Bowel wall. Radiology 234:549–550. https://doi.org/10.1148/radiol.2342031015CrossRefPubMed

69.

Zhang A, Song J, Ma Z, Chen T (2020) Combined dynamic contrast-enhanced magnetic resonance imaging and diffusion-weighted imaging to predict neoadjuvant chemotherapy effect in FIGO stage IB2–IIA2 cervical cancers. Radiol Medica 125:1233–1242. https://doi.org/10.1007/s11547-020-01214-xCrossRef

70.

Addley HC, Vargas HA, Moyle PL, Crawford R, Sala E (2010) Pelvic imaging following chemotherapy and radiation therapy for Gynecologic malignancies. Radiographics 30:1843–1856. https://doi.org/10.1148/rg.307105063CrossRefPubMedPubMedCentral

71.

Ciolina M, Vinci V, Villani L et al (2019) Texture analysis versus conventional MRI prognostic factors in predicting tumor response to neoadjuvant chemotherapy in patients with locally advanced cancer of the uterine cervix. Radiol Medica 124:955–964. https://doi.org/10.1007/s11547-019-01055-3CrossRef

72.

Arrive L, Chang YCF, Hricak H, Brescia RJ, Auffermann W, Quivey JM (1989) Radiation-induced uterine changes: MR imaging. Radiology 170:55–58. https://doi.org/10.1148/radiology.170.1.2909120CrossRefPubMed

73.

Papadopoulou I, Stewart V, Barwick TD et al (2016) Post–radiation therapy imaging appearances in cervical carcinoma. Radiographics 36:538–553. https://doi.org/10.1148/rg.2016150117CrossRefPubMed

74.

Galia M, Albano D, Bruno A et al (2017) Imaging features of solid renal masses. Br J Radiol 90:20170077. https://doi.org/10.1259/bjr.20170077CrossRefPubMedPubMedCentral

75.

Albano D, Agnello F, Midiri F et al (2019) Imaging features of adrenal masses. Insights Imaging 10:1. https://doi.org/10.1186/s13244-019-0688-8CrossRefPubMedPubMedCentral

76.

Christiansen CF, Johansen MB, Langeberg WJ, Fryzek JP, Sørensen HT (2011) Incidence of acute kidney injury in cancer patients: a Danish population-based cohort study. Eur J Intern Med 22:399–406. https://doi.org/10.1016/j.ejim.2011.05.005CrossRefPubMed

77.

Dong J, Yang L, Su T et al (2013) Quantitative assessment of acute kidney injury by noninvasive arterial spin labeling perfusion MRI: a pilot study. Sci China Life Sci 56:745–750. https://doi.org/10.1007/s11427-013-4503-3CrossRefPubMed

78.

Li C, Liu H, Li X, Zhou L, Wang R, Zhang Y (2019) Application of BOLD-MRI in the classification of renal function in chronic kidney disease. Abdom Radiol (NY) 44:604–611. https://doi.org/10.1007/s00261-018-1750-6CrossRef

79.

Schieda N, Malone SC, Al Dandan O, Ramchandani P, Siegelman ES (2014) Multi-modality organ-based approach to expected imaging findings, complications and recurrent tumour in the genitourinary tract after radiotherapy. Insights Imaging 5:25–40. https://doi.org/10.1007/s13244-013-0295-zCrossRefPubMed

80.

Mostafaei S, Abdollahi H, Kazempour Dehkordi S et al (2020) CT imaging markers to improve radiation toxicity prediction in prostate cancer radiotherapy by stacking regression algorithm. Radiol Med 125:87–97. https://doi.org/10.1007/s11547-019-01082-0CrossRefPubMed

81.

Bertocchi E, Barugola G, Nicosia L et al (2020) A comparative analysis between radiation dose intensification and conventional fractionation in neoadjuvant locally advanced rectal cancer: a monocentric prospective observational study. Radiol Medica 125:990–998. https://doi.org/10.1007/s11547-020-01189-9CrossRef

82.

Jereczek-Fossa BA, Surgo A, Maisonneuve P et al (2019) Late toxicity of image-guided hypofractionated radiotherapy for prostate: non-randomized comparison with conventional fractionation. Radiol Medica 124:65–78. https://doi.org/10.1007/s11547-018-0937-9CrossRef

83.

D’Angelillo RM, Fiore M, Trodella LE et al (2020) 18F-choline PET/CT driven salvage radiotherapy in prostate cancer patients: up-date analysis with 5-year median follow-up. Radiol Medica 125:668–673. https://doi.org/10.1007/s11547-020-01167-1CrossRef

84.

Detti B, Baki M, Becherini C et al (2019) High-dose intensity-modulated radiation therapy as primary treatment of prostate cancer: genitourinary/gastrointestinal toxicity and outcomes, a single-institution experience. Radiol Medica 124:422–431. https://doi.org/10.1007/s11547-018-0977-1CrossRef

85.

Onal C, Bozca R, Dolek Y, Guler OC, Arslan G (2020) Incidental testicular doses during volumetric-modulated arc radiotherapy in prostate cancer patients. Radiol Med 125:777–783. https://doi.org/10.1007/s11547-020-01158-2CrossRefPubMed

86.

Herschorn S, Elliott S, Coburn M, Wessells H, Zinman L (2014) SIU/ICUD consultation on urethral strictures: posterior urethral stenosis after treatment of prostate cancer. Urology. https://doi.org/10.1016/j.urology.2013.08.036CrossRefPubMed

87.

Eren T, Pasaoglu L (2020) Splenomegaly in colon cancer during adjuvant oxaliplatin-based chemotherapy. Cureus. https://doi.org/10.7759/cureus.7230CrossRefPubMedPubMedCentral

88.

Imai K, Emi Y, Iyama KI et al (2014) Splenic volume may be a useful indicator of the protective effect of bevacizumab against oxaliplatin-induced hepatic sinusoidal obstruction syndrome. Eur J Surg Oncol 40:559–566. https://doi.org/10.1016/j.ejso.2013.12.009CrossRefPubMed

89.

Hayashi Y, Nishida T, Tsujii M et al (2014) Lymph node enlargement after definitive chemoradiotherapy for clinical stage I esophageal squamous cell carcinoma. BMC Cancer 14:706. https://doi.org/10.1186/1471-2407-14-706CrossRefPubMedPubMedCentral

90.

Brook I (2020) Late side effects of radiation treatment for head and neck cancer. Radiat Oncol J 38:84–92. https://doi.org/10.3857/roj.2020.00213CrossRefPubMedPubMedCentral

91.

Cellina M, Gibelli D, Floridi C, Oliva G (2020) Volumetric analysis of Non-contrast Magnetic Resonance Lymphangiography in patients affected by lower extremities primary lymphedema. Radiol Med 125:432–435. https://doi.org/10.1007/s11547-019-01122-9CrossRefPubMed

92.

Albano D, La Grutta L, Grassedonio E et al (2016) Pitfalls in whole body MRI with diffusion weighted imaging performed on patients with lymphoma: What radiologists should know. Magn Reson Imaging 34:922–931. https://doi.org/10.1016/j.mri.2016.04.023CrossRefPubMed

93.

Williams HJ, Davies AM (2006) The effect of X-rays on bone: a pictorial review. Eur Radiol 16:619–633. https://doi.org/10.1007/s00330-005-0010-7CrossRefPubMed

94.

Chiarilli MG, Delli Pizzi A, Mastrodicasa D et al (2020) Bone marrow magnetic resonance imaging: physiologic and pathologic findings that radiologist should know. Radiol Med. https://doi.org/10.1007/s11547-020-01239-2CrossRefPubMed

95.

Pozzi G, Albano D, Messina C et al (2018) Solid bone tumors of the spine: Diagnostic performance of apparent diffusion coefficient measured using diffusion-weighted MRI using histology as a reference standard. J Magn Reson Imaging 47:1034-1042. https://doi.org/10.1002/jmri.25826CrossRefPubMed

96.

Messina C, Albano D, Gitto S et al (2020) Body composition with dual energy X-ray absorptiometry: from basics to new tools. Quant Imaging Med Surg 10:1687–1698. https://doi.org/10.21037/QIMS.2020.03.02CrossRefPubMedPubMedCentral

97.

Messina C, Piodi LP, Rinaudo L et al (2020) Reproducibility of DXA-based bone strain index and the influence of body mass: an in vivo study. Radiol Med 125:313–318. https://doi.org/10.1007/s11547-019-01118-5CrossRefPubMed

98.

Arpitha A, Rangarajan L (2020) Computational techniques to segment and classify lumbar compression fractures. Radiol Med 125:551–560. https://doi.org/10.1007/s11547-020-01145-7CrossRef

99.

Foti G, Beltramello A, Catania M, Rigotti S, Serra G, Carbognin G (2019) Diagnostic accuracy of dual-energy CT and virtual non-calcium techniques to evaluate bone marrow edema in vertebral compression fractures. Radiol Med 124:487–494. https://doi.org/10.1007/s11547-019-00998-xCrossRefPubMed

100.

Sapienza LG, Salcedo MP, Ning MS et al (2020) Pelvic insufficiency fractures after external beam radiation therapy for gynecologic cancers: a meta-analysis and meta-regression of 3929 patients. Int J Radiat Oncol Biol Phys 106:475–484. https://doi.org/10.1016/j.ijrobp.2019.09.012CrossRefPubMed

101.

Albano D, Patti C, La Grutta L et al (2017) Osteonecrosis detected by whole body magnetic resonance in patients with Hodgkin Lymphoma treated by BEACOPP. Eur Radiol 27:2129–2136. https://doi.org/10.1007/s00330-016-4535-8CrossRefPubMed

102.

Albano D, Patti C, Sconfienza LM, Galia M (2017) Whole-body MRI in the early detection of multifocal osteonecrosis. Br J Radiol. https://doi.org/10.1259/bjr.20170280CrossRefPubMedPubMedCentral

103.

Virtanen A, Pukkala E, Auvinen A (2006) Incidence of bone and soft tissue sarcoma after radiotherapy: a cohort study of 295,712 Finnish cancer patients. Int J Cancer 118:1017–1021. https://doi.org/10.1002/ijc.21456CrossRefPubMed

104.

Delanian S, Lefaix JL (2007) Current management for late normal tissue injury: radiation-induced fibrosis and necrosis. Semin Radiat Oncol 17:99–107. https://doi.org/10.1016/j.semradonc.2006.11.006CrossRefPubMed

105.

Kirchgesner T, Larbi A, Omoumi P et al (2014) Drug-induced tendinopathy: from physiology to clinical applications. Joint Bone Spine 81:485–492. https://doi.org/10.1016/j.jbspin.2014.03.022CrossRefPubMed

106.

Sokolova A, Chan O, Ullah W, Hamdani AA, Anwer F (2017) Delayed rhabdomyolysis with paclitaxel, ifosfamide, carboplatin, and etoposide regimen: a case report. J Med Case Rep 11:100. https://doi.org/10.1186/s13256-017-1272-9CrossRefPubMedPubMedCentral

Title: Imaging side effects and complications of chemotherapy and radiation therapy: a pictorial review from head to toe
Authors: Domenico Albano
Massimo Benenati
Antonio Bruno
Federico Bruno
Marco Calandri
Damiano Caruso
Diletta Cozzi
Riccardo De Robertis
Francesco Gentili
Irene Grazzini
Giuseppe Micci
Anna Palmisano
Carlotta Pessina
Paola Scalise
Federica Vernuccio
Antonio Barile
Vittorio Miele
Roberto Grassi
Carmelo Messina
Young SIRM Working Group
Publication date: 01-12-2021
Publisher: Springer International Publishing
Keywords: Radiotherapy
Cytostatic Therapy
Published in: Insights into Imaging / Issue 1/2021
Electronic ISSN: 1869-4101
DOI: https://doi.org/10.1186/s13244-021-01017-2

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Imaging side effects and complications of chemotherapy and radiation therapy: a pictorial review from head to toe

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 1/2021

CT facilitates improved diagnosis of adult intestinal malrotation: a 7-year retrospective study based on 332 cases

Communicating imaging findings in peritoneal mesothelioma: the impact of ‘PAUSE’ on surgical decision-making

Reply to Letter to the Editor on “Not all biases are bad: equitable and inequitable biases in machine learning and radiology”

Magnetic resonance imaging-based body composition is associated with nutritional and inflammatory status: a longitudinal study in patients with Crohn's disease

Potential role of epicardial adipose tissue as a biomarker of anthracycline cardiotoxicity

Comparison of three embolic materials at partial splenic artery embolization for hypersplenism: clinical, laboratory, and radiological outcomes